ConductScience.org, home
RECK: reversion inducing cysteine rich protein with kazal motifs
API referenceFor AI assistants

Gene · 8434

Papers1,933

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

1 to 20 of 1,933

Download this page as JSON
TitleJournalYearPMIDFound bySource
6PPDQ Promotes Cutaneous Squamous Cell Carcinoma Growth with PI3K-Akt/MMP9 Activation: Evidence from Integrated Network Toxicology and Experimental Investigation.Int J Mol Sci202642794731PubTator, text miningPubMed
Prevalence, Molecular Characterisation and Zoonotic Potential of Blastocystis sp. in Humans and Domestic Animals: A Cross-Sectional Study From Northeastern Iran.Trop Med Int Health202642444081PubTator, text miningPubMed
Functional interaction between miR-505-3p and miR-21 contributes to GBM suppression.Sci Rep202642350583PubTator, text miningPubMed
The Role of miRNA-21 in the Metastasis of Hepatocellular Carcinoma as a Therapeutic Target.Int J Hematol Oncol Stem Cell Res202642293239PubTator, text miningPubMed
Unraveling the Predictive Value of HGF, RECK, CYP1B1, and ZEB2 for Cancer Stemness and Immune Microenvironment in Pancreatic Adenocarcinoma.Stem Cells Int202642147787PubTator, text miningPubMed
A Pragmatic Approach Towards the Molecular Mechanisms of Dexamethasone induced Insulin Resistance and Diabetes Mellitus.Recent Adv Inflamm Allergy Drug Discov202642136448PubTator, text miningPubMed
Role of the WNT signalling pathway in physiological and pathological blood-brain barrier.Ann Med202642007489PubTator, text miningPubMed
Promoter hypomethylation of CDH7: a novel epigenetic marker associated with cerebral small vessel disease.Front Genet202641890232PubTator, text miningPubMed
Advances in the biological functions of miR‑205 in various diseases (Review).Mol Med Rep202641860043PubTator, text miningPubMed
[Matrix metalloproteinases in pituitary adenoma invasiveness].Probl Endokrinol (Mosk)202641834597PubTator, text miningPubMed
An Updated Narrative Review on the Therapeutic Potential of Resveratrol in the Treatment of Cancer.Health Sci Rep202641782655PubTator, text miningPubMed
The ADAM Family of Proteases: Structure, Substrates, and Roles in Liver Diseases.Int J Mol Sci202641751763PubTator, text miningPubMed
Precision Biomarker Identification in Gynecological Cancers Using Coexpression Networks and Attention-Based LSTM in Healthcare 4.0.Diagnostics (Basel)202641750695PubTator, text miningPubMed
CRMP2 inhibits metastasis formation by impairing ILF3-dependent stabilization of CXCL10 mRNA in breast cancer.Cell Death Dis202641735286PubTator, text miningPubMed
The Roles of the Membrane-Anchored Glycoprotein RECK in Animal Development, Tumor Suppression, and Beyond.Life (Basel)202641598259PubTator, text miningPubMed
Venous Endothelial Cells Promote Osteoblast Differentiation More Effectively Than Arterial Cells via TGF-β/BMP9 and Notch Pathway-Related Gene Expression.Cell Biochem Funct202641540952PubTator, text miningPubMed
Single-cell and immune-context integration identifies basement-membrane/metastasis signatures that sharpen bladder-cancer diagnosis and prognosis.Discov Oncol202641533176PubTator, text miningPubMed
Immune activation and microenvironmental crosstalk in hairy cell leukemia.Front Immunol202541726184PubTator, text miningPubMed
Nano-curcumin enhances the sensitivity of tamoxifen-resistant breast cancer cells via the Cyclin D1-DILA1 axis and the PI3K/AKT/mTOR pathway downregulation.PLoS One202541348684PubTator, text miningPubMed
Harmine inhibits ovarian cancer migration and invasion and epithelial-mesenchymal transition (EMT) by inhibiting HDAC7 to restore RECK expression.Biochem Pharmacol202541061932PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Next page

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/8434/papers

API referenceFor AI assistants